Related Experiment Videos
[Primary small cell carcinoma of the bladder]
R Tiguert1, V Ravery, E L Gheiler
1Department of Urology, Wayne State University School of Medicine, Detroit MI, USA.
Summary
Primary small cell carcinoma of the bladder is rare and aggressive. Combination therapy including chemotherapy, surgery, or radiotherapy offers the best survival outcomes for this bladder cancer subtype.
Area of Science:
- Uro-oncology
- Pathology
- Clinical Oncology
Context:
- Primary small cell carcinoma of the bladder is a rare bladder cancer subtype.
- It differs significantly from transitional cell carcinoma in histology, malignancy potential, and treatment strategies.
- This study reviews diagnostic criteria and therapeutic outcomes in a consecutive patient series.
Purpose:
- To analyze diagnostic criteria for primary small cell carcinoma of the bladder.
- To evaluate therapeutic results and survival durations in patients with this rare tumor.
- To determine optimal treatment modalities for improved patient outcomes.
Summary:
- Seven patients with primary small cell carcinoma of the bladder were evaluated.
- All tumors were invasive at diagnosis, with macroscopic hematuria as the common presentation.
- Combination therapy (chemotherapy, surgery, radiotherapy) demonstrated superior survival compared to single-modality treatments.
Impact:
- Primary small cell carcinoma of the bladder carries a poor prognosis.
- Multimodal treatment approaches are crucial for achieving the best possible results.
- Findings emphasize the need for combined neoadjuvant/adjuvant chemotherapy with surgery or radiotherapy.